IDH mutations in acute myeloid leukemia
Authors:
- Sergej KonoplevSKSergej Konoplev
- L. Jeffrey MedeirosLML. Jeffrey Medeiros
- Weina ChenWCWeina Chen
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 43 (10) , 1541-1551
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomasNature Medicine, 2012
- Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid LeukemiaThe Journal of Molecular Diagnostics, 2011
- IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617FLeukemia, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisLeukemia, 2010
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group studyLeukemia, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutationCancer, 2009